Very Late Stent Thrombosis after Discontinuation of Antiplatelet Agents during Anticoagulation Therapy in a Patient with Peri-stent Contrast Staining after Implantation of a Second-generation Drug-eluting Stent
| Autor: | Hiroshi Kawahara, Akihiro Endo, Yu Yasuda, Kazuaki Tanabe, Yusuke Morita, Yuzo Kagawa |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
Male
medicine.medical_specialty medicine.drug_class medicine.medical_treatment Chest pain Internal Medicine medicine Humans cardiovascular diseases Myocardial infarction Staining and Labeling business.industry Anticoagulant Anticoagulants Stent Drug-Eluting Stents Thrombosis General Medicine Middle Aged Left ventricular thrombus equipment and supplies medicine.disease Discontinuation Surgery surgical procedures operative Drug-eluting stent Stents medicine.symptom business Platelet Aggregation Inhibitors |
| Zdroj: | Internal Medicine. 61:1163-1167 |
| ISSN: | 1349-7235 0918-2918 |
| Popis: | A 54-year-old man was admitted to our hospital due to intermittent chest pain. He had a history of acute myocardial infarction, and peri-stent contrast staining had been observed at the stent implantation site. The patient previously underwent anticoagulation therapy for left ventricular thrombus and antiplatelet therapy to prevent stent thrombosis. More than one year after implantation of a drug-eluting stent, antiplatelet drugs were discontinued, and anticoagulant alone was prescribed according to the guidelines, which resulted in very late stent thrombosis. The risks of both bleeding and thrombosis must be fully considered when deciding whether or not to discontinue antiplatelet therapy during anticoagulation therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|